Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (231-240 of 281) with videos related to

Pageof 29
Sort By:
Cancer|April 25, 2003
Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinomaEric C Weinman, Patrick C Roche, Jan L Kasperbauer, et al.
Circulation|February 21, 2008
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic micePeder S Olofsson, Leif A Söderström, Dick Wågsäter, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancerBrian S Henick, Franz Villarroel-Espindola, Ila Datar, et al.
JBMR Plus|December 22, 2023
Anti-Siglec-15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury-Induced Immobilization in RatsYuanzhen Peng, Solomon Langermann, Priyanka Kothari, et al.
Blood|January 4, 2011
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodiesHolbrook E Kohrt, Roch Houot, Matthew J Goldstein, et al.
Blood|June 4, 2008
Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodiesWei Lin, Caroline J Voskens, Xiaoyu Zhang, et al.
Neuro-Oncology|April 29, 2021
Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomasJacky Yeung, Vesal Yaghoobi, Danielle Miyagishima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung CancerJong Woo Lee, Yu Zhang, Kyung Jin Eoh, et al.
Plos One|June 13, 2015
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell SubsetsLiqun Luo, Gefeng Zhu, Haiying Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.
Pageof 29

Showing results (231-240 of 281) with videos related to

Sort By:
Pageof 29
Cancer|April 25, 2003
Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinomaEric C Weinman, Patrick C Roche, Jan L Kasperbauer, et al.
Circulation|February 21, 2008
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic micePeder S Olofsson, Leif A Söderström, Dick Wågsäter, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancerBrian S Henick, Franz Villarroel-Espindola, Ila Datar, et al.
JBMR Plus|December 22, 2023
Anti-Siglec-15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury-Induced Immobilization in RatsYuanzhen Peng, Solomon Langermann, Priyanka Kothari, et al.
Blood|January 4, 2011
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodiesHolbrook E Kohrt, Roch Houot, Matthew J Goldstein, et al.
Blood|June 4, 2008
Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodiesWei Lin, Caroline J Voskens, Xiaoyu Zhang, et al.
Neuro-Oncology|April 29, 2021
Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomasJacky Yeung, Vesal Yaghoobi, Danielle Miyagishima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung CancerJong Woo Lee, Yu Zhang, Kyung Jin Eoh, et al.
Plos One|June 13, 2015
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell SubsetsLiqun Luo, Gefeng Zhu, Haiying Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.
Pageof 29